NCT01709253已完成不适用
Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 117
- 试验地点
- 2
- 主要终点
- clinical outcomes
研究概览
简要总结
Phase 2 hypofractionation study usion proton beam therapy for prostate adenocarcinoma
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Biopsy proven prostate adenocarcinoma Stage: T1-T2cN0M0 ECOG performance status: 0-2 Signed study specific informed consent prior to study entry
排除标准
- •Postoperative residual or recurrent tumor Evidence of distant metastases Previous irradiation for the tumor in the same location Adjuvant anti-androgenic hormonal therapy High risk group (NCCN guide line)
结局指标
主要结局
clinical outcomes
时间窗: up to 5years from a initial follow-up
To evaluate biochemical failure-free survival (BCFFS)
次要结局
- acute toxicity(up to 5years from a initial follow-up)
- late toxicity(up to 5years from a initial follow-up)
- overall survival(up to 5years from a initial follow-up)
研究者
Kwan Ho Cho
M.D.
National Cancer Center, Korea
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular CarcinomaHepatocellular CarcinomaNCT02395523National Cancer Center, Korea45
已完成
不适用
Hypofractionated Proton Beam Radiotherapy for Hepatocellular CarcinomaHepatocellular CarcinomaNCT01643824National Cancer Center, Korea112
进行中（未招募）
2 期
Hypofractionated Proton Beam Therapy for Localized Prostate CancerStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7NCT01950351M.D. Anderson Cancer Center241
招募中
不适用
Prostate Cancer - Localized Adenocarcinoma Proton TherapyProstate AdenocarcinomaNCT03285815National Cancer Center, Korea156
已完成
不适用
Short Course Radiotherapy for Localized Prostate CancerAdenocarcinoma of ProstateNCT03518853Tata Medical Center30